RARA CRAFT DATABASE for FDA Medical Devices

FDA Guidance and Notices, September 2025: Final Computer Software Assurance Guidance and the LDT Rule Vacatur

日本語版

September 2025 is when FDA wrote the court's vacatur of the laboratory developed test (LDT) rule into its regulations. Following the March 31 decision that vacated the 2024 rule, FDA published a final rule on September 19 returning the definition of in vitro diagnostic products to its earlier wording, and the same day withdrew two guidance documents for laboratory manufacturers, among them the LDT small entity compliance guide. Quality teams will also want the final guidance on computer software assurance for production and quality system software, issued September 24.

On September 30, the page for the CDRH Portal, the online submission portal of FDA's Center for Devices and Radiological Health (CDRH), began telling sponsors that from October 1 De Novo requests must be submitted with eSTAR (the electronic Submission Template And Resource), with limited exceptions. FDA also opened a request for comment that day on measuring and evaluating the real-world performance of AI-enabled medical devices. Earlier, on September 12, a Federal Register notice announced a Digital Health Advisory Committee meeting on generative AI-enabled digital mental health medical devices.

Final guidance

In the Federal Register

Device classification rules

Most of these write a classification decided earlier into the regulations; they do not mean any individual product was authorized that day. "Reclassification" changes a device type's class, and "proposed" marks a proposed rule open for comment.

Safety communications and other updates

Also this month

  • September 19: FDA withdrew its May 2024 draft guidance on enforcement policy for certain IVDs used for immediate public health response without a section 564 declaration.
  • September 19: The LDT small entity compliance guide (June 2024) was withdrawn the same day.
  • September 25: FDA withdrew the January 2005 guidance on cybersecurity for networked medical devices containing off-the-shelf (OTS) software.
  • September 25: The companion information for healthcare organizations, from February 2005, went with it.
  • September 29: Early Alerts, which flag potentially high-risk removals and corrections before a recall is formally classified, were expanded from a pilot covering some devices to all medical devices.

Note: dates are FDA issue dates or Federal Register publication dates. Linked pages may now show a later version.

RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.

← All articles